Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose is to investigate tocilizumab administration in patients with moderately to
severely or sight-threatening GO (Graves' ophthalmopathy) without response to treatment with
corticoid intravenous pulses. Currently, these patients only have surgery as therapeutic
alternative.
The principal aim of this study is to evaluate efficacy and safety of tocilizumab treatment
in order to provide a better alternative to surgery for this patients.